These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials. Johnson JL; Wolf SL; Kabadi UM Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835 [TBL] [Abstract][Full Text] [Related]
5. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Krentz AJ; Bailey CJ Drugs; 2005; 65(3):385-411. PubMed ID: 15669880 [TBL] [Abstract][Full Text] [Related]
6. Addressing barriers to initiation of insulin in patients with type 2 diabetes. Peyrot M; Rubin RR; Khunti K Prim Care Diabetes; 2010 Apr; 4 Suppl 1():S11-8. PubMed ID: 20394886 [TBL] [Abstract][Full Text] [Related]
7. Insulin: either alone or combined with oral hypoglycemic agents. Firth RG Prim Care; 1988 Sep; 15(3):665-83. PubMed ID: 3054969 [TBL] [Abstract][Full Text] [Related]
8. Standards of care and the burden of treatment failure in type 2 diabetes. Urquhart BS JAAPA; 2007 Oct; Suppl Initiating Insulin():3-8. PubMed ID: 18050526 [TBL] [Abstract][Full Text] [Related]
9. The use of insulin alone and in combination with oral agents in type 2 diabetes. Buse JB Prim Care; 1999 Dec; 26(4):931-50. PubMed ID: 10523468 [TBL] [Abstract][Full Text] [Related]
10. Strategies for insulin therapy in type 2 diabetes. Edelman SV; Morello CM South Med J; 2005 Mar; 98(3):363-71. PubMed ID: 15813164 [TBL] [Abstract][Full Text] [Related]
11. Insulin plus a sulfonylurea agent for treating type 2 diabetes. Peters AL; Davidson MB Ann Intern Med; 1991 Jul; 115(1):45-53. PubMed ID: 1828656 [TBL] [Abstract][Full Text] [Related]
12. Combination oral agent and insulin therapy for type 2 diabetes mellitus. Passaro MD; Ratner RE Curr Diab Rep; 2001 Oct; 1(2):106-11. PubMed ID: 12643105 [TBL] [Abstract][Full Text] [Related]
13. Diabetes beyond insulin: review of new drugs for treatment of diabetes mellitus. Modi P Curr Drug Discov Technol; 2007 Jun; 4(1):39-47. PubMed ID: 17630927 [TBL] [Abstract][Full Text] [Related]
14. Combination therapy with insulin and sulfonylureas for type II diabetes. Bailey TS; Mezitis NH Diabetes Care; 1990 Jun; 13(6):687-95. PubMed ID: 2192852 [TBL] [Abstract][Full Text] [Related]
15. Pharmacologic therapy for type 2 diabetes mellitus. DeFronzo RA Ann Intern Med; 1999 Aug; 131(4):281-303. PubMed ID: 10454950 [TBL] [Abstract][Full Text] [Related]
16. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy. Vinik A Clin Ther; 2007; 29 Spec No():1236-53. PubMed ID: 18046925 [TBL] [Abstract][Full Text] [Related]
17. Overcoming psychological barriers to insulin use in type 2 diabetes. Brunton SA; Davis SN; Renda SM Clin Cornerstone; 2006; 8 Suppl 2():S19-26. PubMed ID: 16939874 [TBL] [Abstract][Full Text] [Related]
18. Combined insulin-sulfonylurea treatment of type II diabetes. Bingham PR; Riddle MC Diabetes Educ; 1989; 15(5):450-5. PubMed ID: 2673707 [TBL] [Abstract][Full Text] [Related]
19. [Combined insulin and sulfonylurea treatment in diabetes mellitus]. Ravina A; Minuhin O Harefuah; 1986 Jan; 110(1):11-4. PubMed ID: 3514394 [No Abstract] [Full Text] [Related]
20. Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea. Bergenstal R; Lewin A; Bailey T; Chang D; Gylvin T; Roberts V; Curr Med Res Opin; 2009 Jan; 25(1):65-75. PubMed ID: 19210140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]